INVOKAMET XR
Live / Registered — Registered — Section 8 accepted (as of 03 Jun 2023)
What this means for you
Registered since 31 Jan 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86277042
- Registration number
- 5134045
- Mark type
- Stylized text
- Filed
- 09 May 2014
- Published for opposition
- 14 Oct 2014
- Registered
- 31 Jan 2017
- Attorney of record
- Cheryl Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceuticals for the prevention or treatment of metabolic diseases
Owner
- JOHNSON & JOHNSON, New Brunswick, NJ, US
- JOHNSON & JOHNSON, New Brunswick, NJ, US
- JOHNSON & JOHNSON, New Brunswick, NJ, US
Prosecution history
- 31 Jan 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 03 Jun 2023 — SEC. 15 ACKNOWLEDGEMENT - E-MAILED
- 03 Jun 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 03 Jun 2023 — REGISTERED - SEC. 15 ACKNOWLEDGED
- 03 Jun 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 02 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Nov 2022 — TEAS SECTION 15 RECEIVED
- 23 Nov 2022 — TEAS SECTION 8 RECEIVED
- 31 Jan 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 31 Jan 2017 — REGISTERED-PRINCIPAL REGISTER
- 29 Dec 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Dec 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Dec 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Oct 2016 — USE AMENDMENT FILED
- 24 Oct 2016 — TEAS STATEMENT OF USE RECEIVED